Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/2009
09/08/2009US7585515 Curable mixture of a bone substitute, a dianhydride of a dicarboxylic acid and an unsaturated carboxylic acid (dimethacrylic anhydride of sebacic acid and/or 1,3-bis(p-carboxyphenoxy)propane), photoinitiator, and redox catalyst; dental, orthopedic and drug delivery applications
09/08/2009CA2386770C Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
09/03/2009US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
09/03/2009US20090220550 Vaccines for Mycoplasma bovis and methods of use
09/03/2009US20090220535 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
09/03/2009US20090220424 Pro104 Antibody Compositions and Methods of Use
09/02/2009EP1677703A4 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials
09/02/2009EP1651648A4 Compounds and compositions as protein kinase inhibitors
09/02/2009EP1620056B1 Tumor cytotoxicity induced by modulators of the cxcr4 receptor
09/02/2009CN101519449A Modified transferrin fusion proteins
09/02/2009CN100534411C Oxidation dyeing method using N-acetylcysteine as reducing agent and laccase as oxidating agent
09/01/2009US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy
09/01/2009US7582726 cancer therapy utilizing novel vascular endothelial cell growth factor receptor antagonists; immunoglobulin like domain from kinase domain receptor; nucleic acid encoding prolactin receptor antagonizing domain, a VEGF ligand and a cytokine; cell based assay;
09/01/2009US7582478 Cleaved serum response factor in cardiac diagnosis and therapy
09/01/2009US7582297 Methods of treating respiratory conditions
08/2009
08/27/2009US20090215982 Glycopeptide derivatives and pharmaceutical compositions containing the same
08/27/2009US20090215825 Substituted pyrazoles, compositions containing such compounds and methods of use
08/27/2009US20090215795 Cyclic amidine derivatives
08/27/2009US20090215067 Novel lipids for transfection of nucleic acids
08/27/2009US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue
08/27/2009US20090214470 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
08/27/2009US20090214422 DNA encoding a novel RG1 polypeptide
08/26/2009EP1462442B1 Crystals of bicalutamide and process for their production
08/26/2009EP1237915B1 Polynucleotid encoding the rg1 polypeptide
08/26/2009EP1147212B1 T helper cell epitopes
08/26/2009CN101514223A Method for preparation of site-specific protein conjugates
08/25/2009US7579473 c-Met modulators and methods of use
08/25/2009US7579363 Bicyclic compounds and compositions as PDF inhibitors
08/25/2009US7579355 Inhibitors of Akt activity
08/25/2009US7579316 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent
08/25/2009US7579023 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals
08/25/2009CA2439078C Composition improving age-related physiological deficits and increasing longevity
08/20/2009US20090209595 Method of treating of demyelinating diseases or conditions
08/20/2009US20090209594 Method of treating of demyelinating diseases or conditions
08/20/2009US20090209593 Novel antibacterial agents
08/20/2009US20090209505 Prodrugs of heteroaryl compounds
08/20/2009US20090208620 Alimentary Compositions and Methods For Metabolic Modulation
08/20/2009US20090208451 Halogen phosphonate monoesters
08/19/2009EP1485393B1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
08/19/2009CN100528229C Method of inhibiting tumor growth with anti-tissue factor antibodies
08/18/2009US7576127 Aromatic prodrugs of propofol, compositions and uses thereof
08/18/2009US7576122 Ophthalmic compositions for treating ocular hypertension
08/18/2009US7576101 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/18/2009US7576072 Heterocyclic inhibitors of MEK and methods of use thereof
08/18/2009US7576052 Methods and compositions for modulating adipocyte function
08/18/2009US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome
08/18/2009US7575747 Antibodies, or fragments thereof, that are humanized variants of murine antibody 266 which employ complementarity determining regions derived from murine antibody 266; useful for treatment or prevention of conditions associated with A beta, including Alzheimer's disease, Down's syndrome
08/18/2009US7575741 Using interleukin-23 modulators to enhance wound healing
08/18/2009CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
08/13/2009US20090203896 Modulation of survivin expression
08/13/2009US20090203638 Pharmaceutical compositions and methods for metabolic modulation
08/13/2009US20090202618 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
08/12/2009EP1675579B1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses
08/12/2009EP1636221B1 3-Heterocyclyl-Azetidine compounds useful as NK1/NK2 receptors antagonists
08/12/2009EP1592760A4 Solid dispersion compositions
08/12/2009CN101502648A 疫苗 Vaccine
08/12/2009CN100526374C Use of a plastic composition and a product obtained thereby
08/12/2009CN100525835C Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent
08/11/2009US7572922 Substituted pyrazoles, compositions containing such compounds and methods of use
08/11/2009US7572904 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines
08/11/2009US7572828 Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid
08/11/2009US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
08/11/2009US7572804 Macrolides
08/11/2009US7572787 Substituted naphthalene sulfonamides
08/11/2009US7572470 Licorice extract for use as a medicament
08/11/2009US7572462 Peri-operative and peri-procedure nutritional supplementation
08/11/2009US7572454 From Canine Distemper Virus; vaccines; luteinizing hormone releasing hormone
08/11/2009US7572443 Anti-Platelet endothelial cell adhesion molecule (PECAM); monoclonal antibodies; kits
08/11/2009CA2331393C Fatty acid analogues for the treatment of primary and secondary restenosis
08/06/2009US20090197802 Analogues of GLP-1
08/05/2009EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
08/05/2009EP2085096A2 Novel composition and methods for the treatment of immune related diseases
08/05/2009EP1670519A4 Radiolabeled thymidine solid-phase extraction purification method
08/05/2009EP1624884A4 Somatostatin vectors
08/05/2009EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
08/05/2009EP1249233B9 Npyy5 antagonists
08/05/2009CN101497581A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
08/05/2009CN100523192C Vaccines from infectious agents
08/05/2009CN100522991C Peptidomimetic protease inhibitors
08/05/2009CN100522949C Piperazinedione compounds
08/05/2009CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/05/2009CN100522164C Method of treating of demyelinating diseases or conditions
08/04/2009US7569593 Compounds and compositions as protein kinase inhibitors
08/04/2009US7569554 Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
08/04/2009US7569549 Crystallizing in water-miscible solvent, water, and mineral/organic acid
08/04/2009US7569215 Mutant interleukin-2 (IL-2) polypeptides
08/04/2009CA2536251C Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
08/04/2009CA2411047C Stable pharmaceutical solution formulations for pressurised metered dose inhalers
07/2009
07/30/2009US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides
07/30/2009US20090192189 Treatment of cancers expressing p95 erbb2
07/30/2009US20090192099 Prodrugs of heteroaryl compounds
07/30/2009US20090192074 Methods and pharmaceutical compositions for healing wounds
07/30/2009US20090191188 Immunostimulatory nucleic acids
07/30/2009US20090188491 Medicaments
07/29/2009EP1653955A4 Hydroxylamine substituted imidazo-containing compounds
07/29/2009EP1628663B1 Method for producing medicaments for reducing amyloid deposition, amyloid neurotoxicity and microgliosis
07/29/2009CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists
07/29/2009CN100518814C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into biological environmentat from polymer matrix
07/28/2009US7566727 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor
07/28/2009US7566710 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 295